Physician profile
David Levy
NPI 1780608166
$986.93
in general payments reported to CMS, 2019-2025
9 companies · $123 in 2025
The $123 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $15.83 · 2021: $384 · 2022: $97.03 · 2023: $151 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $239.87 | 2021 | |
| Janssen Pharmaceuticals, INC | $187.94 | 2022-2023 | Xarelto |
| Chiesi USA, INC. | $153.01 | 2021-2025 | Cleviprex |
| Pfizer INC. | $133.89 | 2019-2023 | |
| Neurelis, INC. | $121.79 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $107.35 | 2019 | |
| Verona Pharma, INC. | $17.36 | 2025 | Ohtuvayre |
| Glaxosmithkline, LLC. | $15.83 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.